Selling and general expenses growth

STO-REC-STATA6HF0BT2 National
9%

Global · Q2 2026

Selling and general expenses growth came in at 9% in Q2 2026 (Sanofi).

Original source
Publisher
Sanofi
Authority tier
T2 National
Locator
Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
Retrieved
15 Sep 2026
Status
Verified

What the source says

Selling and general expenses reached €2.5 billion, up by 9.0%, mainly because of recent acquisitions and one-offs

Verbatim extraction verified: The figure 9% is directly attested in the quoted passage (Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
Sanofi. (2026). Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded. Retrieved September 15, 2026, from https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Via StatOrigin, https://statorigin.org/stat/stat_A6HF0BBWACAQPH14RXA4X2P01M
MLA
Sanofi. "Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded." 2026, https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_A6HF0BBWACAQPH14RXA4X2P01M.
Chicago
Sanofi. "Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded." 2026. https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_A6HF0BBWACAQPH14RXA4X2P01M.
BibTeX
@misc{sanofi2026sellingx2p01m, author = {{Sanofi}}, title = {Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_A6HF0BBWACAQPH14RXA4X2P01M}, note = {Original source: https://www.sanofi.com/en/media-room/press-releases/2026/2026-07-30-05-30-00-3335767. Accessed September 15, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATA6HF0B T2 National

Primary Source

Publisher
Sanofi · homepage ↗
Authority tier
Tier 2 · National Official
Report
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
Type
Press release
Published
30 July 2026
Locator
Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
Retrieved
15 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_A6HF0BBWACAQPH14RXA4X2P01M